Evidence map›Paper›PMID 34103907›Full record

ArticleInternational journal of chronic obstructive pulmonary disease

Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).

Chunrui Zou, Frank Li, Jiwoong Choi, Babak Haghighi, Sanghun Choi, Prathish K Rajaraman, Alejandro P Comellas, John D Newell, Chang Hyun Lee, R Graham Barr and 16 more

Registry-linked trialAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01969344 (Subpopulations and Intermediate Outcome Measures in COPD Study), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01969344 active not recruitingnot on this map

Subpopulations and Intermediate Outcome Measures in COPD Study

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2010 to 2031Enrolled2,981ConditionsCOPD, Chronic Obstructive Pulmonary Disease, Chronic Bronchitis, Emphysema
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Assessment of ventilation heterogeneity and particle deposition in asthmatics using combined SPECT/CT imaging and computational modeling approaches.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. COPD Phenotyping.Respiratory care · 2023
    Review
  10. A computed tomography imaging-based subject-specific whole-lung deposition model.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Chunrui ZouDepartment of Mechanical Engineering, University of Iowa, Iowa City, IA, USA.ORCID 0000-0002-7482-2678
Frank LiIIHR-Hydroscience & Engineering, University of Iowa, Iowa City, IA, USA.
Jiwoong ChoiDepartment of Mechanical Engineering, University of Iowa, Iowa City, IA, USA.
Babak HaghighiDepartment of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Sanghun ChoiSchool of Mechanical Engineering, Kyungpook National University, Daegu, Republic of Korea.
Prathish K RajaramanDepartment of Mechanical Engineering, University of Iowa, Iowa City, IA, USA.
Alejandro P ComellasDepartment of Internal Medicine, University of Iowa, Iowa City, IA, USA.ORCID 0000-0003-1521-7520
John D NewellDepartment of Radiology, University of Iowa, Iowa City, IA, USA.
Chang Hyun LeeDepartment of Radiology, University of Iowa, Iowa City, IA, USA.
R Graham BarrMailman School of Public Health, Columbia University, New York, NY, USA.
Eugene BleeckerDepartment of Medicine, The University of Arizona, Tucson, AZ, USA.
Christopher B CooperDepartment of Physiology, UCLA, Los Angeles, CA, USA.ORCID 0000-0002-6314-0903
David CouperDepartment of Biostatistics, University of North Carolina, Chapel Hill, NC, USA.ORCID 0000-0002-4313-9235
Meilan HanDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Nadia N HanselSchool of Medicine, Johns Hopkins, Baltimore, MD, USA.
Richard E KannerSchool of Medicine, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0001-6915-599X
Ella A KazerooniDepartment of Radiology, University of Michigan, Ann Arbor, MI, USA.
Eric C KleerupDepartment of Medicine, UCLA, Los Angeles, CA, USA.
Fernando J MartinezWeill Cornell Medicine, Cornell University, New York, NY, USA.ORCID 0000-0002-2412-3182
Wanda O'NealSchool of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Robert PaineSchool of Medicine, University of Utah, Salt Lake City, UT, USA.
Stephen I RennardDepartment of Internal Medicine, University of Nebraska College of Medicine, Omaha, NE, USA.
Benjamin M SmithDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Prescott G WoodruffDepartment of Medicine, University of California at San Francisco, San Francisco, CA, USA.
Eirc A HoffmanDepartment of Biomedical Engineering, University of Iowa, Iowa City, IA, USA.ORCID 0000-0001-8456-9437
Ching-Long LinDepartment of Mechanical Engineering, University of Iowa, Iowa City, IA, USA.

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Amy Leanne Ryan · 1998 to 2026
$30.5M
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progressionU01HL137880 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WOODRUFF, PRESCOTT G · 2017 to 2021
$27.9M
SPIROMICS GIC SupportU24HL141762 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID J, O'NEAL, WANDA K · 2018 to 2022
$7.2M
Chronic obstructive pulmonary disease in non-smokersR01HL130506 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HERBSTMAN, JULIE BETH, SMITH, BENJAMIN M. · 2016 to 2025
$6.3M
Multi-center Structural & Functional Quantitative CT Pulmonary PhenotypingR01HL112986 · NHLBI · UNIVERSITY OF IOWA · PI HOFFMAN, ERIC ALFRED · 2012 to 2016
$4.6M
An integrative statistics-guided image-based multi-scale lung modelU01HL114494 · NHLBI · UNIVERSITY OF IOWA · PI LIN, CHING-LONG · 2013 to 2017
$3.1M
Airway Tree Subtyping on Large Cohorts of CT Images for COPD RiskR01HL155816 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LAINE, ANDREW FRANCIS, SMITH, BENJAMIN M. · 2021 to 2024
$2.4M
Iowa Lung Imaging Training ProgramT32HL144461 · NHLBI · UNIVERSITY OF IOWA · PI HOFFMAN, ERIC ALFRED, REINHARDT, JOSEPH M · 2019 to 2023
$1.6M
Large-Scale Computing and Visualization for Cardiopulmonary ImagingS10RR022421 · NCRR · UNIVERSITY OF IOWA · PI LIN, CHING-LONG · 2008 to 2008
$474k
NCRR NIH HHS S10 RR022421NHLBI NIH HHS R01 HL112986NHLBI NIH HHS R01 HL130506NHLBI NIH HHS R01 HL155816NHLBI NIH HHS T32 HL144461NHLBI NIH HHS U01 HL114494NHLBI NIH HHS U01 HL137880NHLBI NIH HHS U24 HL141762NIDDK NIH HHS P30 DK054759NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

purposeQuantitative computed tomography (qCT) imaging-based cluster analysis identified clinically meaningful COPD former-smoker subgroups (clusters) based on cross-sectional data. We aimed to identify progression clusters for former smokers using longitudinal data. PATIENTS AND

methodsWe selected 472 former smokers from SPIROMICS with a baseline visit and a one-year follow-up visit. A total of 150 qCT imaging-based variables, comprising 75 variables at baseline and their corresponding progression rates, were derived from the respective inspiration and expiration scans of the two visits. The COPD progression clusters identified were then associated with subject demography, clinical variables and biomarkers.

resultsCOPD severities at baseline increased with increasing cluster number. Cluster 1 patients were an obese subgroup with rapid progression of functional small airway disease percentage (fSAD%) and emphysema percentage (Emph%). Cluster 2 exhibited a decrease of fSAD% and Emph%, an increase of tissue fraction at total lung capacity and airway narrowing over one year. Cluster 3 showed rapid expansion of Emph% and an attenuation of fSAD%. Cluster 4 demonstrated severe emphysema and fSAD and significant structural alterations at baseline with rapid progression of fSAD% over one year. Subjects with different progression patterns in the same cross-sectional cluster were identified by longitudinal clustering.

conclusionqCT imaging-based metrics at two visits for former smokers allow for the derivation of four statistically stable clusters associated with unique progression patterns and clinical characteristics. Use of baseline variables and their progression rates enables identification of longitudinal clusters, resulting in a refinement of cross-sectional clusters.

Indexed as

Pulmonary Disease, Chronic ObstructivePulmonary EmphysemaCross-Sectional StudiesHumansOutcome Assessment, Health CareSmokerscomputed tomographyemphysemafunctional small airway diseaselongitudinal clustering

Identifiers

PMID34103907
PMCPMC8178702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.